Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
Marija Darkovska-Serafimovska,1 Tijana Serafimovska,2 Zorica Arsova-Sarafinovska,1 Sasho Stefanoski,3 Zlatko Keskovski,3 Trajan Balkanov4 1Department of Pharmacology, Faculty of Medical Sciences, Goce Delcev University, Stip, Republic of Macedonia; 2Faculty of Pharmacy, Ss Cyril and Methodius Univer...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve--peer-reviewed-article-JPR |
id |
doaj-68d43bbc3bd34eb98b13af2f845b048f |
---|---|
record_format |
Article |
spelling |
doaj-68d43bbc3bd34eb98b13af2f845b048f2020-11-25T00:12:38ZengDove Medical PressJournal of Pain Research1178-70902018-04-01Volume 1183784237909Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseasesDarkovska-Serafimovska MSerafimovska TArsova-Sarafinovska ZStefanoski SKeskovski ZBalkanov TMarija Darkovska-Serafimovska,1 Tijana Serafimovska,2 Zorica Arsova-Sarafinovska,1 Sasho Stefanoski,3 Zlatko Keskovski,3 Trajan Balkanov4 1Department of Pharmacology, Faculty of Medical Sciences, Goce Delcev University, Stip, Republic of Macedonia; 2Faculty of Pharmacy, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia; 3NYSK Holdings, Skopje, Republic of Macedonia; 4Department of Pharmacology and Toxicology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia Purpose: The aim of this review was to assess the efficacy of cannabis preparations for relieving pain in patients with malignant diseases, through a systematic review of randomized controlled trials (RCTs), which were predominantly double-blind trials that compared cannabis preparation to a placebo.Methods: An electronic search of all literature published until June 2017 was made in MEDLINE/PubMed, Embase, The Cochrane Controlled Trials Register and specific web pages devoted to cannabis.Results: Fifteen of the 18 trials demonstrated a significant analgesic effect of cannabinoids as compared to placebo. The most commonly reported adverse effects were generally well tolerated, mild to moderate. The main side effects were drowsiness, nausea, vomiting and dry mouth. There is evidence that cannabinoids are safe and modestly effective in neuropathic pain and also for relieving pain in patients with malignant diseases. The proportion of “responders” (patients who at the end of 2 weeks of treatment reported ≥30% reduction in pain intensity on a scale of 0–10, which is considered to be clinically important) was 43% in comparison with placebo (21%). Conclusion: The target dose for relieving pain in patients with malignant diseases is most likely about 10 actuations per day, which is about 27 mg tetrahydrocannabinol (THC) and 25 mg cannabidiol (CBD), and the highest approved recommended dose is 12 actuations per day (32 mg THC/30 mg CBD). Further large studies of cannabinoids in homogeneous populations are required. Keywords: cancer management, chronic pain, cannabidiol, tetrahydrocannabinol, medical marihuana, nabiximols, cannabinoid receptorshttps://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve--peer-reviewed-article-JPRCannabinoidspainmalignant diseasestetrahydrocannabinol (THC) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Darkovska-Serafimovska M Serafimovska T Arsova-Sarafinovska Z Stefanoski S Keskovski Z Balkanov T |
spellingShingle |
Darkovska-Serafimovska M Serafimovska T Arsova-Sarafinovska Z Stefanoski S Keskovski Z Balkanov T Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases Journal of Pain Research Cannabinoids pain malignant diseases tetrahydrocannabinol (THC) |
author_facet |
Darkovska-Serafimovska M Serafimovska T Arsova-Sarafinovska Z Stefanoski S Keskovski Z Balkanov T |
author_sort |
Darkovska-Serafimovska M |
title |
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
title_short |
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
title_full |
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
title_fullStr |
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
title_full_unstemmed |
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
title_sort |
pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases |
publisher |
Dove Medical Press |
series |
Journal of Pain Research |
issn |
1178-7090 |
publishDate |
2018-04-01 |
description |
Marija Darkovska-Serafimovska,1 Tijana Serafimovska,2 Zorica Arsova-Sarafinovska,1 Sasho Stefanoski,3 Zlatko Keskovski,3 Trajan Balkanov4 1Department of Pharmacology, Faculty of Medical Sciences, Goce Delcev University, Stip, Republic of Macedonia; 2Faculty of Pharmacy, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia; 3NYSK Holdings, Skopje, Republic of Macedonia; 4Department of Pharmacology and Toxicology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia Purpose: The aim of this review was to assess the efficacy of cannabis preparations for relieving pain in patients with malignant diseases, through a systematic review of randomized controlled trials (RCTs), which were predominantly double-blind trials that compared cannabis preparation to a placebo.Methods: An electronic search of all literature published until June 2017 was made in MEDLINE/PubMed, Embase, The Cochrane Controlled Trials Register and specific web pages devoted to cannabis.Results: Fifteen of the 18 trials demonstrated a significant analgesic effect of cannabinoids as compared to placebo. The most commonly reported adverse effects were generally well tolerated, mild to moderate. The main side effects were drowsiness, nausea, vomiting and dry mouth. There is evidence that cannabinoids are safe and modestly effective in neuropathic pain and also for relieving pain in patients with malignant diseases. The proportion of “responders” (patients who at the end of 2 weeks of treatment reported ≥30% reduction in pain intensity on a scale of 0–10, which is considered to be clinically important) was 43% in comparison with placebo (21%). Conclusion: The target dose for relieving pain in patients with malignant diseases is most likely about 10 actuations per day, which is about 27 mg tetrahydrocannabinol (THC) and 25 mg cannabidiol (CBD), and the highest approved recommended dose is 12 actuations per day (32 mg THC/30 mg CBD). Further large studies of cannabinoids in homogeneous populations are required. Keywords: cancer management, chronic pain, cannabidiol, tetrahydrocannabinol, medical marihuana, nabiximols, cannabinoid receptors |
topic |
Cannabinoids pain malignant diseases tetrahydrocannabinol (THC) |
url |
https://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve--peer-reviewed-article-JPR |
work_keys_str_mv |
AT darkovskaserafimovskam pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases AT serafimovskat pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases AT arsovasarafinovskaz pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases AT stefanoskis pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases AT keskovskiz pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases AT balkanovt pharmacotherapeuticconsiderationsforuseofcannabinoidstorelievepaininpatientswithmalignantdiseases |
_version_ |
1725398476893716480 |